These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7634495)
21. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody. Ochi Y; Kajita Y; Hamazu M; Nagata A Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785 [TBL] [Abstract][Full Text] [Related]
22. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients. Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640 [TBL] [Abstract][Full Text] [Related]
23. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
24. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy. Molnár I; Balázs C Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165 [TBL] [Abstract][Full Text] [Related]
25. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease. Endo T; Kobayashi T J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203 [TBL] [Abstract][Full Text] [Related]
26. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy. Jaume JC; Prummel MF; Wiersinga WM; McLachlan SM; Rapoport B Thyroid; 1993; 3(4):291-5. PubMed ID: 7509670 [TBL] [Abstract][Full Text] [Related]
27. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785 [TBL] [Abstract][Full Text] [Related]
28. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Morris JC; Hay ID; Nelson RE; Jiang NS Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572 [TBL] [Abstract][Full Text] [Related]
29. [Polymorphism of the 52 triplet gene (nucleotide 253) of the TSH receptor in Basedow-Graves patients and in healthy controls]. Kaczur V; Szalai C; Falus A; Nagy Z; Krajczár G; Balázs C Orv Hetil; 1997 Jun; 138(25):1625-8. PubMed ID: 9265143 [TBL] [Abstract][Full Text] [Related]
30. [Mouse model of Graves' disease]. Nagayama Y Nihon Rinsho; 2005 Oct; 63 Suppl 10():62-5. PubMed ID: 16279604 [No Abstract] [Full Text] [Related]
31. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563 [TBL] [Abstract][Full Text] [Related]
32. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor. Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies. Kim WB; Chung HK; Park YJ; Park DJ; Lee HK; Cho BY Korean J Intern Med; 2001 Sep; 16(3):187-200. PubMed ID: 11769578 [TBL] [Abstract][Full Text] [Related]
34. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras]. Tahara K; Yamamoto K; Tamura Y; Yoshida S Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118 [TBL] [Abstract][Full Text] [Related]
35. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy. Salvi M; Bingoye F; Chung F; Wall JR J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902 [TBL] [Abstract][Full Text] [Related]
39. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769 [TBL] [Abstract][Full Text] [Related]
40. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries. Park JY; Kim IJ; Lee MH; Seo JK; Suh PG; Cho BY; Ryu SH; Chae CB Endocrinology; 1997 Feb; 138(2):617-26. PubMed ID: 9002995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]